Pharmaceuticals Stocks

Ligand Pharmaceuticals Inc Valuation – September 2018 $LGND

Ligand Pharmaceuticals Inc. does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the insufficient earnings stability or growth over the last ten years, and the poor dividend history, and the high PEmg and PB ratios.

Read More
Pharmaceuticals Stocks

Ligand Pharmaceuticals Inc Valuation – Initial Coverage $LGND

Ligand Pharmaceuticals Inc. does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, insufficient earnings stability or growth over the last ten years, the poor dividend history, and the high PEmg and PB ratios.

Read More
Back To Top